EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients

Rajkishen Narayanan, Jonathan Dalton, Michael A McCurdy, Tariq Z Issa, Robert J Oris, Alexa Tomlak, Yunsoo Lee, Kenneth McCall, Dodger Norceide, John J Mangan, Mark F Kurd, Ian David Kaye und 5 weitere

European Spine Journal · 2025

DOI: 10.1007/s00586-025-08764-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Spine Journal, 2025. Verfasst von Rajkishen Narayanan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Rothman Orthopaedic Institute at Thomas Jefferson University Hospital, 925 Chestnut St, 5th Floor, Philadelphia, P…. Hauptthemen laut MEDLINE: Spinal Fusion, Gabapentin, Postoperative Pain, Analgesics, Opioid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Treatment of preoperative depression has been shown to reduce pain perception and disability after spine surgery, which encouraged utilizing antidepressants as a treatment for pain. Though opioid consumption after spine surgery has been well studied, few studies have investigated its association with medications such as antidepressants and gabapentinoids. Therefore, our study investigated the relationship between antidepressants, gabapentinoids and opioid consumption after lumbar fusion.

Methods

After Institutional Review Board (IRB) approval, patients undergoing elective lumbar fusion from 2017 to 2021 at a single, academic, tertiary care center were identified. Patients were determined to be taking an antidepressant or gabapentinoid if they had these medications listed as active in their preoperative and first postoperative appointments. Opioid consumption before and after surgery was collected through the state Prescription Drug Monitoring Program (PDMP). Statistics were performed to compare patients across groups.

Results

411 patients were identified that underwent elective lumbar fusion with complete patient-reported outcomes and PDMP data. On multivariable analysis, preoperative morphine milligram equivalents (MMEs) were an independent predictor of postoperative MME/day at all postoperative time points. Perioperative SNRI use was predictive of increased 90–180 day MME/day ( p = 0.019). Perioperative gabapentinoid use was predictive of increased MME/day at 30–90 days ( p = 0.034) and 180–365 days ( p = 0.024).

Conclusion

A complex relationship exists between the medical management of mood disorders and neuropathic pain using antidepressants, anxiolytics, and gabapentinoids for patients undergoing spinal surgery. Patients prescribed gabapentinoids and SNRIs are at increased risk of opioid use postoperatively while patients taking SSRIs do not demonstrate such increased risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal FusionGabapentinPostoperative PainAnalgesics, OpioidLumbar VertebraeSerotonin and Noradrenaline Reuptake InhibitorsAntidepressive AgentsSelective Serotonin Reuptake InhibitorsHumansFemaleMaleMiddle AgedAgedAdultRetrospective StudiesDepression

Stichwörter der Autor:innen

GabepentinoidLumbar fusionOpioidsSNRISSRI

Substanzen

GabapentinAnalgesics, OpioidSerotonin and Noradrenaline Reuptake InhibitorsAntidepressive AgentsSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Rothman Orthopaedic Institute at Thomas Jefferson University Hospital, 925 Chestnut St, 5th Floor, Philadelphia, PA, 19107, USA.
  • Department of Orthopaedic Surgery, Rothman Orthopaedic Institute at Thomas Jefferson University Hospital, 925 Chestnut St, 5th Floor, Philadelphia, PA, 19107, USA. rajkishen.narayanan@gmail.com.

Zitieren

APA

Narayanan, R., Dalton, J., A McCurdy, M., Z Issa, T., Oris, R. J., Tomlak, A., Lee, Y., McCall, K., Norceide, D., Mangan, J. J., F Kurd, M., Kaye, I. D., Canseco, J. A., Hilibrand, A. S., Vaccaro, A. R., Kepler, C. K., & Schroeder, G. D. (2025). Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients. European Spine Journal. https://doi.org/10.1007/s00586-025-08764-6

Vancouver

Narayanan R, Dalton J, A McCurdy M, Z Issa T, Oris RJ, Tomlak A, et al. Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients. European Spine Journal. 2025. doi:10.1007/s00586-025-08764-6

BibTeX
@article{Narayanan2025,
  author = {Narayanan, Rajkishen and Dalton, Jonathan and A McCurdy, Michael and Z Issa, Tariq and Oris, Robert J and Tomlak, Alexa and Lee, Yunsoo and McCall, Kenneth and Norceide, Dodger and Mangan, John J and F Kurd, Mark and Kaye, Ian David and Canseco, Jose A and Hilibrand, Alan S and Vaccaro, Alexander R and Kepler, Christopher K and Schroeder, Gregory D},
  title = {Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients},
  journal = {European Spine Journal},
  year = {2025},
  doi = {10.1007/s00586-025-08764-6}
}
Kostenlos starten →